Genetic Technologies Limited (GENE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 9.76M |
| Enterprise Value | 9.62M |
| P/E Ratio | -0.45 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.74 |
| Price/Book Ratio | 2.95 |
| Enterprise/Revenue | 0.72 |
| Enterprise/EBITDA | -0.48 |
| Fiscal Year | June 30, 2024 |
| Most Recent Quarter | June 30, 2024 |
| Profit Margin | -1.57 |
| Operating Margin | -1.59 |
| Return On Assets | -1.94 |
| Return On Equity | -1.85 |
| Revenue | 7.66M |
| Revenue/Share | 0.06 |
| Gross Profit | 3.9M |
| EBITDA | -11.43M |
| Net Income | -12.02M |
| Diluted EPS | -2.73 |
| Total Cash | 1.02M |
| Total Cash/Share | 0.01 |
| Total Debt | 875,189 |
| Total Debt/Equity | 0.48 |
| Current Ratio | 0.88 |
| Book Value Per Share | 0.01 |
| 52-Week Change | -75.48 |
| 52-Week High | 3.59 |
| 52-Week Low | 0.67 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 1.07 |
| Average Volume | 0 |
| Shares Outstanding | 145.42M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | December 14, 2023 |